MedTrace Logo

An Observational Study to Evaluate the ETX-4143 Device in Subjects With Ocular Hypertension

NCT06709300 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-07-11

No results posted yet for this study

Summary

This study aims to assess the effectiveness of the EyeCool ETX-4143 device in reducing intraocular pressure (IOP) in eyes with ocular hypertension, regardless of a formal diagnosis of primary open-angle glaucoma. The primary objective is to determine whether the EyeCool device can effectively lower IOP in individuals with elevated eye pressure. Participants currently using intraocular pressure-lowering medications but still experiencing elevated IOP may also be eligible to participate.

Conditions

Sponsors & Collaborators

  • EyeCool Therapeutics, Pty Ltd

    collaborator UNKNOWN

  • EyeCool Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Patrick R Casey, OD · EyeCool Therapeutics, Inc.

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2026-06-30
Completion
2026-07-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06709300 on ClinicalTrials.gov